Found 33 matching trials
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy PHASE3 Primary Objective:
To compare the efficacy of insulin glargine (U300) and ...
Show More Location
Investigational Site Number 1560039
Learn More & Join Trial
Degludec Glargine U300 Hospital Study NA Limited data exist about the use of insulin degludec and insulin glargine U...
Show More Location
Division Of Endocrinology and Diabetes , Medanta The Medicity Hospital
Learn More & Join Trial
Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients PHASE3 Primary Objective:
The primary objective of this study is to obtain effica...
Show More Location
Investigational Site Number 124001
Learn More & Join Trial
Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatment PHASE4 Primary Objective:
The primary objective is to describe the effect of insu...
Show More Location
Investigational Site Number 250017
Learn More & Join Trial
Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo PHASE3 Primary Objective:
To demonstrate the non-inferiority of the MyStar DoseCo...
Show More Location
Investigational Site Number 276002
Learn More & Join Trial
Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors PHASE4 To compare the impact of insulin degludec (IDeg-100) and insulin glargine U...
Show More Location
Klinički bolnički Centar Split
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin PHASE3 Primary Objective:
* To compare the efficacy of insulin glargine new formu...
Show More Location
Investigational Site Number 840156
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey PHASE4 Primary Objective:
To assess the mean change in HbA1c (glycated haemoglobi...
Show More Location
Multiple Locations
Learn More & Join Trial
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM PHASE3 Primary Objective:
To demonstrate the ease of use of the U300 pen injector...
Show More Location
Investigational Site Number 276011
Learn More & Join Trial
Glargine U300 Hospital Trial PHASE4 The purpose of this study is to find out if treatment with Glargine U300 wh...
Show More Location
Grady Memorial Hospital
Learn More & Join Trial